Genomics

$209,037P30FY2015CANIH

Wayne State University, Detroit MI

Investigators

Linked publications & trials

Paper 39684782 Paper 39661958 Paper 39606471 Paper 39503807 Paper 39395780 Paper 39341857 Paper 39320947 Paper 39320053 Paper 39207730 Paper 39173312 Paper 39172022 Paper 39104719 Paper 39104440 Paper 39091864 Paper 39085349 Paper 39070618 Paper 39048308 Paper 39032654 Paper 38916900 Paper 38856749 Paper 38830035 Paper 38817898 Paper 38801647 Paper 38733583 Paper 38712049 Paper 38705005 Paper 38624208 Paper 38561433 Paper 38521153 Paper 38519053 Paper 38464167 Paper 38377173 Paper 38373550 Paper 38347107 Paper 38334664 Paper 38289997 Paper 38281248 Paper 38280205 Paper 38266099 Paper 38263486 Paper 38201517 Paper 38113368 Paper 38081370 Paper 38013223 Paper 37986911 Paper 37952249 Paper 37863410 Paper 37798594 Paper 37779259 Paper 37771843 Paper 37760566 Paper 37684289 Paper 37623859 Paper 37604291 Paper 37578347 Paper 37503132 Paper 37395113 Paper 37348680 Paper 37342043 Paper 37231419 Paper 37211866 Paper 37184135 Paper 37162954 Paper 37153742 Paper 37148545 Paper 37118900 Paper 37039784 Paper 37036634 Paper 36935617 Paper 36934365 Paper 36798315 Paper 36779039 Paper 36764888 Paper 36736426 Paper 36723416 Paper 36644397 Paper 36587730 Paper 36525371 Paper 36377055 Paper 36319643 Paper 36288741 Paper 36255393 Paper 36243227 Paper 36208684 Paper 36058202 Paper 36046053 Paper 35968582 Paper 35938683 Paper 35929183 Paper 35893261 Paper 35847859 Paper 35819414 Paper 35790779 Paper 35756137 Paper 35753939 Paper 35727144 Paper 35713967 Paper 35655423 Paper 35645376 Paper 35634303

Abstract

The Genomics Core provides consultation and state-of-the-art genomic technologies to KCI investigators. Core scientists interact with KCI researchers to design experiments, generate preliminary data, write methodologies, and generate and analyze experimental data. The Core supports research investigating genetic factors: a) responsible for cancer susceptibility, b) involved in neoplastic initiation and progression, and c) affecting cancer treatment. Existing Core technologies include: 1) nucleic acid isolation (Qiagen TissueLyser, AutoPure and EZ1 Advanced); 2) DNA sequencing (Applied Biosystems 3730 and 3100); 3) genotyping (Applied Biosystems 7900, lllumina iScan, and Affymetrix GeneChip System); 4) expression analysis (Applied Biosystems 7900, lllumina iScan, and Affymetrix GeneChip System); and 5) Next Generation Sequencing (lllumina Genome Analyzer NX with paired-end module).

View original record on NIH RePORTER →